Stock Screener App

無料 -

インストール

Exchange Traded Fund

34.90

0.37% 0.1298

Tema Etf Trust Tema Obesity Cardiometabolic Etf (HRTS)

概要ニュース株価時系列ディスカッション予測

Tema Etf Trust Tema Obesity Cardiometabolic Etf (HRTS) 最新ニュース

5 Small-cap Biotech ETFs to Watch (Updated 2024) - Investing News Network

5 Small-cap Biotech ETFs to Watch (Updated 2024) - Nasdaq

Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS) Shares Up 0.1% - Defense World

Beyond Novo and Eli Lilly: Watch these biotech and weight loss drug names, fund manager says - CNBC

HRTS: Generating Alpha In Obesity Treatment (NASDAQ:HRTS) - Seeking Alpha

ETFs in Focus as Competition Heats Up in Weight Loss Drug Segment - Yahoo Finance

HRTS: Exposure To GLP-1 Drug Developers Means Plenty Of Upside - Seeking Alpha

ETF Innovators: 11 people disrupting the industry, creating unique products, and delivering mammoth returns - Business Insider

ETF Innovators: 11 disruptive people with unique products, high return - Business Insider

EXCLUSIVE: GLP-1 Weight-Loss Drugs Could Become A Trillion-Dollar Market, Predicts Tema ETFs CEO - Benzinga

This ETF is trying to satisfy appetites for weight loss stocks - CNBC

ETF IQ: Mutual Fund Managers Have the Luxury to Just Say 'No' - Bloomberg

ETF IQ: Mutual Fund Managers Have the Luxury to Just Say ‘No’ - Bloomberg

Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS) Stock Price Down 1.1% - Defense World

Spot Ether ETF: a Crypto Game Changer? - Opto RoW

ETFs to Profit from the Weight Loss Drug Boom - Zacks Investment Research

ETFs to Profit from the Weight Loss Drug Boom - Yahoo Finance

OZEM, Weight Loss Drug ETFs: Should You Invest? - etf.com

Investing in the diabesity epidemic: a breakthrough moment - Opto RoW

Obesity Market to Reach $150B as Demand Grows, Supply Stabilizes: Reuters - BioSpace

Ethereum Surges: Spot ETFs Drive Growth For the Second Largest Cryptocurrency - The Globe and Mail

Play These New ETFs to Tap Lucrative Weight Loss Drug Market - Zacks Investment Research

Play These New ETFs to Tap Lucrative Weight Loss Drug Market - Yahoo Finance

Thematic ETF Winners of the Q1 2024 Earnings Season - ETF Trends

S&P 500: April Selloff Could Be a Very Good Thing for the Months Ahead - Investing.com India

IBD Stock Of The Day Pops After Obesity Drug Crushes Sales Views - Investor's Business Daily

The Impact of Bitcoin Halving on Investors and ETFs to Explore - The Globe and Mail

A New Horizon: Horizons ETF Management Canada to rebrand as Global X - The Globe and Mail

Webcast: How to Invest in the Weight Loss Drug Revolution - ETF Trends

This weight-loss ETF has performed well. Here’s a look at other options. - MarketWatch

Healthcare ETFs for the Weight-Loss Drug Boom & Beyond - Zacks Investment Research

Healthcare ETFs for the Weight-Loss Drug Boom & Beyond - Yahoo Finance

Is the global battle against obesity an opportunity for investors? - InvestmentNews

First Weight Loss ETF from Tema ETFs Announces Name Change, Tops $50 Million AUM - Markets Insider

Feisty Rivals Take On Eli Lilly, Novo Nordisk On Weight Loss - Investor's Business Daily

'Continued innovation' is key when investing in weight loss trend - Yahoo Finance

Weight-Loss Drugs: How Outliers Like Biohaven, Regeneron Are Taking On The Muscle Dilemma In The Obesity Space - Investor's Business Daily

The Truth HRTSETF Focus on TheStreet: ETF research and Trade Ideas - TheStreet

US ETF launches from 16th to 23rd November, 2023 - ETF Express

New ETF invested in Ozempic maker and exposed to other obesity drugs falls in first day of trade - MarketWatch

New ETF Tracks Developers of Obesity Drugs Amid Ozempic Hype - BNN Bloomberg

New ETF Tracks Developers of Obesity Drugs Amid Ozempic Hype - Wealth Management

$172.73

0.74%

$373.93

0.46%

$61.16

0.59%

$82.08

0.67%

$365.47

0.39%

$472.87

0.54%

Yahooで開く | Google で開く | Finviz で開く | Open in MarketWatch | Open in Reuters